The NIH Common Fund and the American Reinvestment and Recovery Act (ARRA)


The Common Fund is using ARRA funds to provide seven new early-stage investigators with NIH Director's New Innovator (DP2) Awards, making a total of fifty-two New Innovator awards in fiscal year 2009. The New Innovator award supports investigators with exceptionally innovative research ideas, but not necessarily preliminary data, to pursue projects that are inherently risky but have the potential for exceptional impact on biomedicine. The emphasis of the New Innovator award is on innovation and creativity. This award complements ongoing efforts by NIH and its institutes and centers to fund new investigators through R01 grants and other mechanisms. Unlike other types of NIH awards, the New Innovator Awards provide recipients with the necessary funds needed to pursue the project, with no annual budget requested in the application.

The ARRA supported New Innovator Awards address a range of scientific areas, including:

View ARRA funded research...

This page last reviewed on June 15, 2015